Meniere's Disease
Also known as: Endolymphatic Hydrops
Meniere's disease is a chronic inner ear disorder characterized by recurring episodes of vertigo, fluctuating hearing loss, tinnitus, and a feeling of fullness in the affected ear. The exact cause is unknown but is associated with abnormal fluid buildup (endolymph) in the inner ear. Episodes can be debilitating and typically affect one ear, though both ears may eventually become involved.
Last updated November 10, 2026
Understanding Meniere's Disease
Meniere's disease is an inner ear disorder that produces attacks of spinning vertigo lasting 20 minutes to 12 hours, together with hearing loss, tinnitus and a blocked or full feeling in one ear. The current diagnostic criteria, agreed by the Barany Society and adopted in the 2020 American Academy of Otolaryngology-Head and Neck Surgery guideline, require at least two such attacks plus a hearing test that documents low- to mid-frequency sensorineural loss in the affected ear. It affects roughly 190 people per 100,000 in the United States, or about 615,000 people, usually starting between 40 and 60 and slightly more often in women. It is rare in children. Most people start with one ear involved; over a decade or more, somewhere between a quarter and 40 percent develop symptoms in the second ear as well.
The inner ear contains two fluids, perilymph and endolymph, separated by thin membranes. In Meniere's disease the endolymph compartment swells (endolymphatic hydrops), and the leading explanation for an attack is that a membrane ruptures or stretches, mixing the two fluids and bathing the balance and hearing nerve endings in potassium-rich endolymph, which briefly disables them. Why the fluid builds up is unknown: immune, genetic, vascular and viral factors have all been implicated, and hydrops is also seen on MRI in some people without symptoms, so it is probably necessary but not sufficient. The natural course is a slow burn. Attacks tend to cluster, then fade; in long-term follow-up, vertigo settled on its own in about 60 percent of people within two years and 70 percent within eight. Hearing follows the opposite path, fluctuating early and then settling into a fixed loss that averages about 50 decibels after ten years.
The 2020 AAO-HNS clinical practice guideline is cautious because the trial evidence is thin. It supports a trial of sodium restriction and limiting caffeine and alcohol, and allows diuretics, while acknowledging that neither has been proven in a well-run placebo-controlled trial. Betahistine, the most prescribed Meniere's drug worldwide, was tested properly in the BEMED trial (221 people, nine months, BMJ 2016) and performed no better than placebo at either 48 or 144 mg a day. Acute attacks are managed with short courses of vestibular suppressants such as meclizine or a benzodiazepine, plus an anti-nausea drug, not continued between attacks because they slow the brain's compensation. For people with frequent attacks despite these measures, injections through the eardrum work well: in a 60-person randomized trial (Lancet 2016), intratympanic methylprednisolone and intratympanic gentamicin each cut attacks by about 90 percent at two years, with the steroid avoiding gentamicin's risk to hearing. Vestibular rehabilitation helps the chronic unsteadiness between attacks, hearing aids address the loss, and surgery (endolymphatic sac decompression, labyrinthectomy or vestibular nerve section) is reserved for the few who fail everything else.
No supplement has been shown to prevent Meniere's attacks or protect hearing, and it is better to know that than to spend money on the bioflavonoid blends marketed for this diagnosis, which have no published trial support. The honest list is short and symptom-based. Ginger reduces nausea and vomiting, including vertigo-provoked nausea, in several small trials and is a sensible thing to keep at home for attacks. Ginkgo biloba extract matched betahistine in a 12-week vertigo trial, but that trial was not in Meniere's disease specifically, and ginkgo does nothing for tinnitus in Cochrane's review. Low vitamin D has been linked to Meniere's in observational studies, and correcting a deficiency reduced recurrence of a different inner ear problem (benign positional vertigo) in a large trial, so it is worth checking a vitamin-d level and replacing it if low, without expecting it to stop attacks. Melatonin has two small trials showing less bothersome tinnitus and better sleep. Diuretic herbs, magnesium and 'inner ear' formulas have no evidence here.
The most common mistake is to drive, climb ladders or swim alone during a cluster of attacks on the assumption that a warning will come in time. Vertigo can begin within seconds and about one in ten people with longstanding disease develops Tumarkin drop attacks, a sudden fall without warning or loss of consciousness. During an active phase, do not drive, and tell your clinician about any drop attack because it changes the treatment plan. The second mistake is taking meclizine or diazepam every day as prevention: these drugs blunt the brain's ability to recalibrate to a damaged ear and leave people chronically unsteady. Use them for the hours of an attack and then stop.
At a Glance
- Common symptoms
- Recurring episodes of vertigo lasting 20 minutes to several hours, Fluctuating hearing loss that may become permanent, Tinnitus (ringing, buzzing, or roaring in the ear)
- Main treatments
- Low-sodium diet to reduce fluid retention, Diuretics (hydrochlorothiazide, triamterene), Vestibular rehabilitation therapy
- Category
- Eye & Ear · Affects approximately 615,000 people in the United States
- See a doctor if
- Sudden onset of vertigo with hearing changes
Symptoms
Causes
- Abnormal accumulation of endolymphatic fluid in the inner ear
- Possible autoimmune component
- Genetic predisposition
- Viral infection of the inner ear
Risk Factors
- Age 40–60 years
- Family history of Meniere's disease
- Pre-existing autoimmune conditions
- History of head trauma or ear infections
- High sodium diet
Diagnosis
- Audiometry showing low- to mid-frequency sensorineural hearing loss
- Electronystagmography (ENG) or videonystagmography (VNG)
- Electrocochleography (ECoG)
- MRI to rule out acoustic neuroma or other structural causes
Treatment
- Low-sodium diet to reduce fluid retention
- Diuretics (hydrochlorothiazide, triamterene)
- Vestibular rehabilitation therapy
- Betahistine (used in many countries outside the US)
- Intratympanic steroid or gentamicin injections for refractory cases
- Endolymphatic sac decompression surgery in severe cases
Natural remedies for meniere's disease: what the evidence says
Ranked by the strength of human evidence for meniere's disease specifically. These sit alongside medical care, not in place of it.
Ginger
Preliminary evidenceIn a placebo-controlled crossover study, 1 g of powdered ginger root reduced the vertigo and nausea produced by caloric stimulation of the inner ear in healthy volunteers, and in an 80-person trial at sea it reduced vomiting and cold sweats compared with placebo. Pooled trials of ginger for nausea of other causes show a consistent modest benefit. There is no trial in Meniere's disease itself, so its role is symptom relief during attacks rather than prevention.
- Studied dose
- 1 g dried ginger root (capsules) at the first sign of an attack, repeated once after 4 hours if needed; ginger tea or crystallized ginger is a weaker alternative.
- Cautions
- Mild heartburn in some people. Ginger has a small antiplatelet effect, so mention it if you take warfarin or other blood thinners and stop it a week before surgery.
Ginkgo Biloba
Preliminary evidenceA 12-week randomized double-blind trial in 160 adults with vertigo of mixed causes found ginkgo extract EGb 761 (240 mg a day) produced the same improvement in vertigo scores as betahistine 32 mg a day, with fewer side effects. The participants were not selected for Meniere's disease, and betahistine itself failed against placebo in the BEMED trial, so equivalence is not proof of benefit. Cochrane's 2013 review found no effect of ginkgo on tinnitus.
- Studied dose
- 120 mg of standardized EGb 761 extract twice daily; trials ran for 12 weeks.
- Cautions
- Increases bleeding risk with warfarin, apixaban, clopidogrel and aspirin; stop 2 weeks before surgery. Avoid with seizure disorders and do not combine with other serotonergic or blood-thinning supplements.
Vitamin D
Preliminary evidenceSeveral case-control studies have found lower 25-hydroxyvitamin D levels in people with Meniere's disease than in matched controls, and vitamin D receptors are present in the inner ear. In a 957-person randomized trial (Neurology 2020) in people with benign paroxysmal positional vertigo, replacing low vitamin D cut recurrences by 24 percent, but no equivalent trial exists for Meniere's. Checking a level and correcting deficiency is reasonable; expecting it to stop attacks is not.
- Studied dose
- If a blood level is below 20 ng/mL, 1,000 to 2,000 IU of vitamin D3 daily with a meal, rechecking the level after 3 months.
- Cautions
- Do not exceed 4,000 IU daily without monitoring. Raises calcium absorption, so use care with thiazide diuretics (often prescribed for Meniere's), which also raise calcium, and in sarcoidosis or kidney stones.
Melatonin
Preliminary evidenceTinnitus is often the most distressing symptom between attacks. In a 61-person randomized crossover trial, 3 mg of melatonin at bedtime for 30 days reduced tinnitus intensity and improved sleep more than placebo, with the largest benefit in men and in people with louder tinnitus. An earlier 30-person trial found improvement mainly in those whose sleep was disturbed by the noise. Neither trial measured vertigo or hearing.
- Studied dose
- 3 mg immediate-release melatonin 30 to 60 minutes before bed, for at least 4 weeks.
- Cautions
- Morning grogginess at higher doses; interacts with warfarin, fluvoxamine and nifedipine. US supplement content varies widely from the label, so choose a third-party-tested product.
What matters day to day
- Keep sodium under 1,500 to 2,000 mg a day and spread it evenly across meals: the goal is to avoid swings in body fluid balance, and a single salty restaurant meal is a more common trigger than a steadily moderate diet.
- During an attack, lie down, fix your eyes on one still object and do not try to walk: most attacks last 2 to 3 hours, and falls during vertigo are the main source of injury in this condition.
- Do between-attack vestibular rehabilitation exercises prescribed by a physical therapist: they retrain the brain to rely on the good ear and the eyes, and improve the chronic unsteadiness that about half of people report.
- Keep a diary of attacks alongside sleep, stress, weather, menstrual cycle and what you ate: identifiable personal triggers are found in a sizeable minority, and the record also shows whether a treatment is working.
- Protect your hearing in the affected ear and get a baseline audiogram repeated yearly: loud noise does not cause Meniere's but adds to the loss, and documented decline is what justifies escalating treatment.
- Ask to be assessed for migraine: vestibular migraine coexists with or mimics Meniere's in a large share of people, and treating migraine with sleep regularity, hydration and a preventive medication can reduce 'Meniere's' attacks.
Prevention
- Limit dietary sodium to less than 1,500–2,000 mg per day
- Manage stress through relaxation techniques
- Avoid caffeine, alcohol, and tobacco
- Stay well hydrated
When to See a Doctor
- Sudden onset of vertigo with hearing changes
- Hearing loss that worsens progressively
- Vertigo episodes that interfere with daily activities
- New tinnitus or ear pressure that persists
Frequently Asked Questions
References
- Basura GJ, Adams ME, Monfared A, et al.. Clinical practice guideline: Meniere's disease. Otolaryngology-Head and Neck Surgery (2020)
- Lopez-Escamez JA, Carey J, Chung WH, et al.. Diagnostic criteria for Meniere's disease. Journal of Vestibular Research (2015)
- Adrion C, Fischer CS, Wagner J, et al.. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ (2016)
- Patel M, Agarwal K, Arshad Q, et al.. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Meniere's disease: a randomised, double-blind, comparative effectiveness trial. Lancet (2016)
- Alexander TH, Harris JP. Current epidemiology of Meniere's syndrome. Otolaryngologic Clinics of North America (2010)
- Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere's disease. Otolaryngology-Head and Neck Surgery (1989)
- Sokolova L, Hoerr R, Mishchenko T. Treatment of vertigo: a randomized, double-blind trial comparing efficacy and safety of Ginkgo biloba extract EGb 761 and betahistine. International Journal of Otolaryngology (2014)
- Jeong SH, Kim JS, Kim HJ, et al.. Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: a randomized trial. Neurology (2020)
- Hurtuk A, Dome C, Holloman CH, et al.. Melatonin: can it stop the ringing?. Annals of Otology, Rhinology and Laryngology (2011)
- National Institute on Deafness and Other Communication Disorders. Meniere's Disease (2023)View source
Related Conditions
Have questions about Meniere's Disease?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.